All Stories

  1. Economic Evaluation of Lenalidomide (Revlimid®) for the Treatment of Myelodysplastic Syndrome

    Article • Global & Regional Health Technology Assessment, January 2017, SAGE Publications

    Arely Lemus Carmona

  2. Cost-Effectiveness of Azacitidine Compared with Low-Doses of Chemotherapy (LDC) in Myelodysplastic Syndrome (MDS)

    Article • Global & Regional Health Technology Assessment, January 2017, SAGE Publications

    Arely Lemus Carmona